Enter your login e-mail to the account
Search
- Use of biological treatment in oncology
MUDr. Michal Mego, MUDr. Lucia Masárová
(6/2011, Review articles )
- The use of monoclonal antibodies in neurology
prof. MUDr. Egon Kurča, PhD., MUDr. Mária Cuninková
(6/2011, Main topic ) - Kmenové buňky: Současný stav laboratorního výzkumu a perspektivy léčby míšního poranění
MUDr. Tomáš Soukup1, MUDr. Jana Karbanová1, doc. MUDr. Jaroslav Mokrý, Ph.D., MUDr. Petr Suchomel, Ph.D.
(2/2005, Main topic )
- News in the treatment of lung cancer
doc. MUDr. Peter Beržinec, CSc.
(4/2012, Review articles ) - Treatment of EGFR- mutated non-small cell lung cancer – update
MUDr. Gabriela Chowaniecová, prof. MUDr. Dalibor Ondruš, DrSc.
(1/2021, Main topic ) - Molecular Testing for Selection of Patients With Lung Cancer for Epidermal Growth Factor Receptor and Anaplastic Lymphoma Kinase Tyrosine Kinase Inhibitors
doc. MUDr. Peter Beržinec, CSc.
(6/2014, Information & comments ) - 13th Central European Lung Cancer Conference, Praha, 24. – 27. 6. 2012
doc. MUDr. Peter Beržinec, CSc.
(4/2012, Events ) - Publikujeme v zahraničí
doc. MUDr. Michal Mego, PhD.
(4/2012, Information & comments ) - The pathologist´s contribution for a targeted biological therapy of neoplastic disorders
prof. MUDr. Lukáš Plank, CSc.
(1/2011, Review articles ) - Targeted biological therapy for lung cancer – current status and perspectives
doc. MUDr. Peter Beržinec, CSc.
(1/2011, Review articles ) - Biological treatment of the small cell lung cancer
MUDr. Peter Kasan
(1/2007, Review articles ) - Lung cancer in elderly
doc. MUDr. Mária Wagnerová, CSc.
(1/2007, Review articles ) - Capecitabine and its role in the treatment of advanced HER2 positive breast cancer
doc. MUDr. Igor Andrašina, CSc., MUDr. Radovan Barilla, PhD.
(1/2011, Review articles ) - Current options in the treatment of HER2 low metastatic breast cancer
MUDr. Radovan Barila, PhD.
(2/2024, Review articles ) - Publikujeme v zahraničí
(1/2011, Information & comments ) - 10. stredoeurópska konferencia o rakovine pľúc
doc. MUDr. Peter Beržinec, CSc.
(2/2006, Events ) - CARDIOVASCULAR COMPLICATIONS OF SELECTED ANTICANCER AGENTS – NEW INSIGHTS INTO PATHOGENESIS AND DIAGNOSTICS
doc. MUDr. Beáta Mladosievičová, CSc., MUDr. Silvia Cingelová
(2/2008, Review articles ) - Novinky z ASCO 2006
MUDr. Tomáš Šálek, MUDr. Radovan Barilla,
(3/2006, Events ) - Personalized medicine approach in metastatatic colorectal cancer
MUDr. Vanda Ušáková, PhD.
(6/2013, Review articles ) - Adjuvant therapy of colorectal cancer in elderly patients
doc. MUDr. Mária Wagnerová, CSc., doc. MUDr. Alexander Berč, CSc.
(4/2007, Review articles ) - Molecular markers of targeted therapy in oncology malignancies
RNDr. Katarína Hlinková
(2/2010, Review articles ) - Biological treatment with monoclonal antibody
MUDr. Andrey Švec, PhD., PharmDr. Andrea Gažová, PhD., prof. PharmDr. Ján Kyselovič, CSc.
(2/2019, Review articles ) - How to improve the first line treatment of NSCLC with EGFR mutation?
doc. MUDr. Peter Beržinec, CSc.
(6/2016, Review articles ) - Treatment of ALK-rearranged non-small cell lung cancer
MUDr. Zuzana Pribulová
(6/2015, Main topic ) - Contemporary possibilities of adrenocortical carcinoma treatment
doc. MUDr. Ján Ľupták, PhD., prof. MUDr. Ján Kliment, CSc., MUDr. Boris Eliáš, PhD., prof. MUDr. Ján Švihra, PhD., MUDr. Ján Kliment jr.
(1/2013, Review articles ) - Treatment of patients with HR+, HER2- PIK3CA-mutated advanced/metastatic breast cancer: results of trial SOLAR-1
MUDr. Andrej Rosík
(2/2021, Review articles ) - Inflammatory breast cancer
doc. MUDr. Mária Wagnerová, CSc.
(2/2012, Main topic ) - Significance of neoadjuvant treatment in patients with early breast cancer – perspective of surgeon
MUDr. Marián Karaba, prof. MUDr. Juraj Benca, PhD., MPH, MUDr. Terézia Lauková, doc. MUDr. Daniel Pinďák, PhD., MUDr. Dominika Rusnáková, MUDr. Martina Vranovská, MUDr. Otília Osifová
(2/2017, Review articles ) - Metastatic colorectal cancer – results of treatment of the primary tumor localization
MUDr. Vanda Ušáková, PhD.
(2/2017, Review articles ) - Publikujeme v zahraničí
(6/2015, Information & comments ) - Cetuximab – a chimeric monoclonal IgG1 antibody for the treatment of patients with squamous cell cancer of the head and neck
doc. PharmDr. Juraj Sýkora, CSc.
(6/2009, Drugs & drug classes ) - Circulating tumor DNA in non-small cell lung cancer patients with epidermal growth factor receptor mutations
MUDr. Michal Urda, MUDr. Simona Laštíková, MUDr. Juraj Mazal, prof. MUDr. Eva Rozborilová, CSc.
(5/2020, Review articles ) - Systemic treatment of bladder cancer – neoadjuvant, adjuvant and palliative chemotherapy
MUDr. Branislav Bystrický, MUDr. Filip Kohútek, MUDr. Peter Kohútek, MUDr. Tomáš Sedláček
(3/2016, Review articles ) - Treatment of advanced metastatic lung cancer in older patients
doc. MUDr. Peter Beržinec, CSc.
(5/2012, Main topic ) - 14. svetová konferencia o karcinóme pľúc v Amsterdame
doc. MUDr. Peter Beržinec, CSc.
(5/2011, Events ) - Publikujeme v zahraničí
(5/2011, Information & comments ) - Anti-EGFR treatment in colorectal cancer – what is ist role today and in the future?
MUDr. Filip Kohútek, PhD., MUDr. Branislav Bystrický, PhD., MPH
(5/2019, Review articles ) - Myelodysplastic syndrome – classification, pathophysiology
prof. MUDr. Elena Tóthová, CSc.
(1/2014, Spectrum ) - New mechanism of action in the treatment of renal cell carcinoma: m-TOR – a novel target
MUDr. Hana Študentová, prof. MUDr. Bohuslav Melichar, Ph.D.
(5/2010, Review articles ) - Castration resistant prostate cancer – something new in the year 2014?
doc. MUDr. Jozef Marenčák, PhD.
(4/2014, Main topic ) - Etiopathogenesis of cervical cancer
MUDr. Oliver Sadovský, CSc., prof. RNDr. Ján Vojtaššák, CSc.
(5/2010, Review articles ) - Ras genes of metastatic colorectal carcinoma
RNDr. Katarína Hlinková
(4/2014, Review articles ) - The combination of cetuximab and radiotherapy in the first line treatment of colorectal carcinoma – The Slovak project
MUDr. Tomáš Šálek, MUDr. Marián Streško, MUDr. Jozef Chovanec, MUDr. Eduard Šebo, MUDr. Dagmar Mazalová, MUDr. Alena Thomková, a ďalší
(5/2010, Original articles & case reports ) - Neratinib in treatment of HER2+ breast cancer – drug profile
MUDr. Radovan Barila, PhD.
(3/2020, Drugs & drug classes ) - Why do some lung cancer patients receive no anticancer treatment?
doc. MUDr. Peter Beržinec, CSc.
(5/2010, Information & comments ) - Osteoblastic flare effect during targeted therapy in lung adenocarcinoma
MUDr. Gabriela Chowaniecová
(4/2013, Original articles & case reports ) - Publikujeme v zahraničí
(4/2013, Information & comments ) - Nové perspektívy v liečbe pokročilého a metastatického HR+ HER2- karcinómu prsníka
MUDr. Miroslava Malejčíková, MUDr. Silvia Jurišová
(2/2018, Review articles ) - Dual inhibition after failure of NSAI as a solution to hormone therapy resistance
MUDr. Bibiána Vertáková Krakovská, PhD.
(1/2015, Review articles ) - Eribulin in treatment of breast cancer
doc. MUDr. Mária Wagnerová, CSc., MUDr. Hana Garanová
(1/2015, Drugs & drug classes ) - Trastuzumab deruxtecan – drug profile and use in the treatment of advanced HER2-positive breast cancer
MUDr. Radovan Barila, PhD., MUDr. Lenka Svobodová, MUDr. Ján Bujňák, PhD.
(2/2022, Drugs & drug classes ) - Systemic treatment of advanced, persistent or recurrent cervical cancer
MUDr. Mária Rečková
(4/2015, Review articles ) - Lung cancer molecular testing in Slovak Republic – view clinical practise
doc. MUDr. Peter Beržinec, CSc., MUDr. Peter Kasan, MUDr. Andrea Cipková, MPH., MUDr. Mária Černá, CSc., MUDr. Róbert Godál, MUDr. Gabriela Chowaniecová, MUDr. Igor Andrašina, CSc.
(6/2015, Main topic ) - Current options and perspectives of both adjuvant and neoadjuvant therapy of cholangiocarcinoma
MUDr. Patrik Palacka, PhD., MUDr. Iveta Vochyanová-Andrezálová
(1/2010, Review articles ) - Antineoplastic treatment of patients with renal insufficency
MUDr. Ján Rajec, PhD., doc. MUDr. Michal Mego, PhD.
(2/2011, Review articles ) - BIOPHARMACEUTICALS IN ONCOLOGY
doc. PharmDr. Juraj Sýkora, CSc.
(3/2008, Review articles ) - WHAT ARE WE ABLE TO ACHIEVE IN THE TREATMENT OF METASTATIC NON-SMALL CELL LUNG CANCER TODAY?
doc. MUDr. Peter Beržinec, CSc.
(3/2008, Original articles ) - Skin toxicity of EGFR inhibitors
MUDr. Katarína Poláková, PhD.
(6/2016, Review articles ) - 9TH TH WORLD CONGRESS ON GASTROINTESTINAL CANCER, 27. – 30. JÚN 2008, BARCELONA
MUDr. Tomáš Šálek
(3/2008, Events ) - Molecular biology of colorectal cancer from the perspective of the pathologist
MUDr. Michal Kalman
(5/2014, Main topic ) - Immunotherapy for lung cancer
doc. MUDr. Peter Beržinec, CSc.
(4/2016, Main topic ) - Non small-cell lung cancer and treatment options after tyrosine kinase inhibitors failure in the first line
MUDr. Gabriela Chowaniecová
(5/2014, Original articles & case reports ) - Dual EGFR mutation in patient with non-small cell lung cancer
MUDr. Martin Horný, MUDr. Lucia Doláková, MUDr. Kristína Šuhajdová, MUDr. Klaudia Grácová
(2/2023, Main topic ) - Publikujeme v zahraničí
(4/2016, Information & comments ) - Publikujeme v zahraničí
(1/2012, Information & comments ) - Optimization of treatment of colorectal cancer
MUDr. Iveta Andrezálová Vochyanová
(5/2015, Review articles ) - Publikujeme v zahraničí
(5/2015, Information & comments ) - Monoclonal antibodies in antitumorous therapy and infectious complications
MUDr. Ľuboš Drgoňa, CSc.
(6/2010, Review articles ) - Neoadjuvant therapy of triple-negative breast cancer
MUDr. Bibiána Vertáková Krakovská, PhD.
(4/2020, Review articles ) - Chemotherapy in combination with radiotherapy in locally advanced head and neck carcinoma
doc. MUDr. Pavol Dubinský, PhD.
(2/2015, Review articles ) - PARP inhibitors
prof. MUDr. Stanislav Špánik, CSc.
(6/2010, Review articles ) - Personalization of treatment of colorectal cancer in 1st line
MUDr. Štefan Pörsök, PhD., MUDr. Natália Pazderová, MUDr. Ján Slopovský, MUDr. Tomáš Šálek
(4/2020, Main topic ) - Optimal first-line treatment of mCRC
MUDr. Jana Ďurková
(1/2017, Review articles ) - ERBITUX®: cielená blokáda egfr zvyšuje účinnosť liečby
MUDr. Lenka Slanináková
(1/2006, Review articles ) - Actual therapeutic strategy of patients with non small cell lung cancer with EML4-ALK rearrangement
MUDr. Juraj Mazal, MUDr. Michal Urda, RNDr. Anna Farkašová, PhD.
(1/2017, Review articles ) - Treatment of BRAF wt metastatic colorectal cancer
MUDr. Vanda Ušáková, PhD.
(4/2021, Review articles ) - INTERNATIONAL MEETING ON INNOVATIVE APPROACHES IN HEAD AND NECK ONCOLOGY,BARCELONA 2007
MUDr. Tibor Barta, PhD.
(3/2007, Events ) - CLEAR CELL OVARIAN CANCOR – A CASE STORY
doc. MUDr. Lýdia Heľpianska, CSc., MUDr. Ivana Krajčovičová
(2/2006, Original articles ) - Metronomic chemotherapy in breast cancer
MUDr. Bibiána Vertáková Krakovská, PhD.
(1/2018, Review articles ) - Zaujímavosti z literatúry
doc. MUDr. Peter Beržinec, CSc.
(3/2009, Information & comments ) - CHEMOTHERAPY OF THE HEAD AND NECK TUMOR´S
MUDr. Dagmar Sorkovská
(3/2007, Review articles - treatment ) - Management of skin toxicities associated with epidermal growth factor inhibitor cetuximab in combination with chemotherapy or radiotherapy
MUDr. Katarína Poláková
(6/2011, Review articles ) - Glukokortikoidy v liečbe kastračne-rezistentného karcinómu prostaty a mechanizmy rezistencie na androgénnu blokádu
JUDr. MUDr. Patrik Palacka, PhD., MPH, MBA, LL.M.
(4/2018, Review articles ) - COMPLETE REMISION AFTER CETUXIMAB WITH IRINOTECAN IN COMBINATION WITH SURGICAL TREATMENT IN PRETREATED PATIENT (CASE REPORT)
MUDr. Jozef Šufliarsky
(3/2007, Original articles )
- Cutaneous adverse effects of targeted oncologic therapies
MUDr. Katarína Poláková, PhD.
(1/2016, Topic of the year ) - Progress in the biological treatment of psoriasis
Prof. MUDr. Mária Šimaljaková, PhD
(1/2018, Drugs & drug classes ) - Healing of wounds with hyaluronic acid
MUDr. Katarína Poláková, PhD.
(1/2012, Review articles ) - Ki-67 antigen and p53 protein expression in basal cell carcinoma of the skin – a topic review
MUDr. Milada Kullová, MUDr. Vladimír Bartoš, PhD.
(2-3/2013, Review articles ) - Acne-like rash and another skin toxicities associated with administration of HER1/EGFR inhibitors
MUDr. Katarína Poláková, PhD.
(1/2010, Review articles )
- CHEMOTHERAPY OF THE HEAD AND NECK TUMOR´S
MUDr. Dagmar Sorkovská
(3-4/2007, clearly )
- Healing of wounds with hyaluronic acid
MUDr. Katarína Poláková, PhD.
(4/2011, Current pharmacotherapy )












